{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:04:52Z","timestamp":1750219492423,"version":"3.41.0"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.2025-3-5","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:42:57Z","timestamp":1750156977000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of dupilumab in the treatment of moderate-to-severe atopic dermatitis: a real-life study"],"prefix":"10.7573","volume":"14","author":[{"given":"Mariele","family":"Morandin Lopes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Moschione Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00falio","family":"Morandin Ferrisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariana","family":"Campos Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Morato Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10047","published-online":{"date-parts":[[2025,6,19]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2025\/06\/dic.2025-3-5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:42:58Z","timestamp":1750156978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/efficacy-and-safety-of-dupilumab-in-the-treatment-of-moderate-to-severe-atopic-dermatitis-a-real-life-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.2025-3-5","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]}}}